Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks

NCT01068600 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

318

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Indacaterol
DRUG: Placebo to indacaterol

Sponsor

Novartis